Lipid CME
LECTURECME

Best of Preventive Cardiology Summit: Applying New Options for Optimal CV Risk Management

Author(s)/Faculty: David J. Davidson, MD, FACC; Michael H. Davidson, MD, FACC, FACP, FNLA; Martha Gulati, MD, MS, FACC, FAHA, FASPC; Carl E. Orringer, MD, FAAC, FNLA; Matthew J. Sorrentino, MD, FACC, FAHA; Laurence S. Sperling, MD, FAAC, FACP, FAHA, FASPC
Release Date: 1/21/2020Expiration Date: 1/20/2021
Credit Type: CMENumber of Credits: 1.25
Content Type: LectureProvider:
In the United States, cardiovascular disease (CVD) is the leading cause of death, claiming over 800,000 lives annually. Cardiologists play a significant role in the prevention of CVD via the management of risk factors; yet training in preventive cardiology is inadequate, and options for managing CVD risk are expanding rapidly. This CME-certified activity is designed for fellows in cardiology or CVD prevention and other health care professionals to advance their knowledge regarding care of patients with CVD. Highlights of the Fellows Summit for Preventive Cardiology: Applying New Options for Optimal CV Risk Management include evidence-based guidelines on low-density lipoprotein cholesterol-lowering treatment to reduce CVD risk in patients with dyslipidemia as well as the safety and efficacy of proprotein convertase subtilisin/kexin type 9 inhibitors. The complex relationship between type 2 diabetes mellitus and CVD risk and the importance of managing additional risk factors will also be examined.